Merck
CN
Search Within

909866

Applied Filters:
Keyword:'909866'
Showing 1-8 of 8 results for "909866" within Papers
pH-sensitive polymers for drug delivery
Huh K M,et al.
Macromolecular Research, 20(3), 224?233-224?233 (2012)
Jing Xie et al.
Macromolecular rapid communications, 38(23), 1499-1499 (2017-10-05)
Since diabetes mellitus has become one of the most serious threats to human health, researchers have been designing new drugs and developing new technologies to control the blood glucose level (BGL) while improving patient compliance. In addition to the traditional
Hong-ming Ding et al.
Scientific reports, 3, 2804-2804 (2013-10-01)
The major challenge in cancer therapy is to efficiently translocate drug molecules into cancer tumors without doing any damage to healthy tissues. Since there exist pH gradients between tumor and normal tissues, pH-sensitive materials may have great potential to overcome
pH-Responsive polymers
Kocak G , et al.
Polym. Chem., 8, 144?176-144?176 (2017)
Cationic Salecan-based hydrogels for release of 5-fluorouracil.
Qi X, et al.
Royal Society of Chemistry Advances, 7, 14337-14347 (2017)
Themis R Kyriakides et al.
Journal of controlled release : official journal of the Controlled Release Society, 78(1-3), 295-303 (2002-01-05)
Cytosolic delivery from endosomes is critical for those drugs that are susceptible to attack by lysosomal enzymes, such as DNA, RNA, oligonucleotides, proteins and peptides. Therefore, we have designed pH-sensitive, membrane-disruptive polymers to enhance the release of drugs from the
Prithankar Pramanik et al.
Macromolecular rapid communications, 37(18), 1499-1506 (2016-07-23)
The synthesis, micellar aggregation, and pH-triggered intracellular drug delivery ability of an amphiphilic statistical copolymer (P2) are studied. Two methacrylate derivatives, one containing a hydrophilic pendant and the other containing a hydrophobic pendant chain, are copolymerized to produce P2. The
Girish Kumar Tripathi et al.
Current drug delivery, 8(6), 667-677 (2012-02-09)
Helicobacter pylori reside in the gastric mucus layer and at the mucus-epithelial cell interface wherein access of antimicrobial drug to the infection site is restricted both from the stomach and from the gastric blood supply. The aim of the present
Page 1 of 1